Literature DB >> 17550373

CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages.

Y Nishioka1, K Manabe, J Kishi, W Wang, M Inayama, M Azuma, S Sone.   

Abstract

Interferon-inducible protein-10 (IP-10)/CXCL10, which is a ligand for CXC chemokine receptor 3 (CXCR3), is known to be involved in the pathogenesis of pulmonary sarcoidosis. However, the roles of monokine induced by interferon gamma (Mig)/CXCL9 and interferon-inducible T cell alpha chemoattractant (I-TAC)/CXCL11, which are also CXCR3 ligands, remain unclear. Mig/CXCL9, IP-10/CXCL10 and I-TAC/CXCL11 in both bronchoalveolar lavage fluid (BALF) and serum in patients with pulmonary sarcoidosis were measured by enzyme-linked immunosorbent assay (ELISA). The expression of these chemokines in alveolar macrophages was examined using ELISA, quantitative real-time polymerase chain reaction and immunostaining. In BALF, Mig/CXCL9 and IP-10/CXCL10 were significantly elevated in stage II sarcoidosis as compared with the levels in healthy volunteers. In serum, Mig/CXCL9 and I-TAC/CXCL11 were increased in stage II of the disease. The levels of all CXCR3 ligands in BALF were correlated with the numbers of both total and CD4(+) lymphocytes. Alveolar macrophages were stained positive for all CXCR3 ligands and produced increased amounts of these chemokines. Positive staining of the three chemokines was also observed in the epithelioid and giant cells in the sarcoid lungs. These findings suggest that Mig/CXCL9 and I-TAC/CXCL11 as well as IP-10/CXCL10 play important roles in the accumulation of Th1 lymphocytes in sarcoid lungs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17550373      PMCID: PMC1941950          DOI: 10.1111/j.1365-2249.2007.03423.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

Review 1.  Sarcoidosis: clinical update.

Authors:  U Costabel
Journal:  Eur Respir J Suppl       Date:  2001-09

Review 2.  Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower; Roland M du Bois
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

3.  Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases.

Authors:  D Miotto; P Christodoulopoulos; R Olivenstein; R Taha; L Cameron; A Tsicopoulos; A B Tonnel; O Fahy; J J Lafitte; A D Luster; B Wallaert; C E Mapp; Q Hamid
Journal:  J Allergy Clin Immunol       Date:  2001-04       Impact factor: 10.793

4.  Increased macrophage inflammatory protein-1alpha and macrophage inflammatory protein-1beta levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis.

Authors:  Armando Capelli; Antonino Di Stefano; Mirco Lusuardi; Isabelle Gnemmi; Claudio F Donner
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

5.  Human monocyte-derived and CD83(+) blood dendritic cells enhance NK cell-mediated cytotoxicity.

Authors:  Y Nishioka; N Nishimura; Y Suzuki; S Sone
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

6.  IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs.

Authors:  K Shigehara; N Shijubo; M Ohmichi; R Takahashi; S Kon; H Okamura; M Kurimoto; Y Hiraga; T Tatsuno; S Abe; N Sato
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

7.  Elevation of macrophage-derived chemokine in eosinophilic pneumonia: a role of alveolar macrophages.

Authors:  Kazuyoshi Manabe; Yasuhiko Nishioka; Jun Kishi; Mami Inayama; Yoshinori Aono; Yoichi Nakamura; Fumitaka Ogushi; Hiroyasu Bando; Kenji Tani; Saburo Sone
Journal:  J Med Invest       Date:  2005-02

8.  Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.

Authors:  David Xiao-Ming Zhao; Yenya Hu; Geraldine G Miller; Andrew D Luster; Richard N Mitchell; Peter Libby
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

9.  Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice.

Authors:  Hisatsugu Goto; Seiji Yano; Helong Zhang; Yuka Matsumori; Hirohisa Ogawa; David C Blakey; Saburo Sone
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

10.  Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.

Authors:  John A Belperio; Michael P Keane; Marie D Burdick; Joseph P Lynch; Ying Ying Xue; Kewang Li; David J Ross; Robert M Strieter
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

View more
  20 in total

1.  Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa.

Authors:  Christine Bäuerl; Marta Llopis; María Antolín; Vicente Monedero; Manuel Mata; Manuel Zúñiga; Francisco Guarner; Gaspar Pérez Martínez
Journal:  Genes Nutr       Date:  2012-06-06       Impact factor: 5.523

2.  The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10.

Authors:  Keiji Tanese; Elizabeth A Grimm; Suhendan Ekmekcioglu
Journal:  Int J Cancer       Date:  2011-10-23       Impact factor: 7.396

Review 3.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

4.  Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures.

Authors:  Haruhiko Furusawa; Jonathan H Cardwell; Tsukasa Okamoto; Avram D Walts; Iain R Konigsberg; Jonathan S Kurche; Tami J Bang; Marvin I Schwarz; Kevin K Brown; Jonathan A Kropski; Mauricio Rojas; Carlyne D Cool; Joyce S Lee; Paul J Wolters; Ivana V Yang; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

5.  Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis.

Authors:  Nicholas K Arger; Melissa Ho; Prescott G Woodruff; Laura L Koth
Journal:  Respir Med       Date:  2019-04-17       Impact factor: 3.415

6.  CXCR3 in T cell function.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Exp Cell Res       Date:  2011-03-10       Impact factor: 3.905

7.  Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study.

Authors:  Katerina M Antoniou; Giannoula Soufla; Athanasia Proklou; George Margaritopoulos; Christiana Choulaki; Rena Lymbouridou; Katerina D Samara; Demetrios A Spandidos; Nikolaos M Siafakas
Journal:  Clin Dev Immunol       Date:  2010-02-14

8.  No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis.

Authors:  Maria Wikén; Farah Idali; Muntasir Abo Al Hayja; Johan Grunewald; Anders Eklund; Jan Wahlström
Journal:  Respir Res       Date:  2010-09-02

Review 9.  Dendritic cells in the pathogenesis of sarcoidosis.

Authors:  Lisa C Zaba; Gideon P Smith; Miguel Sanchez; Stephen D Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-16       Impact factor: 6.914

10.  CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis.

Authors:  Nicholas K Arger; Melissa E Ho; Isabel E Allen; Bryan S Benn; Prescott G Woodruff; Laura L Koth
Journal:  Respir Med       Date:  2019-11-20       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.